EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Low-dose antithymocyte globulin for treatment of steroid-pulse-resistant acute graft-versus-host disease



Low-dose antithymocyte globulin for treatment of steroid-pulse-resistant acute graft-versus-host disease



International Journal of Hematology 77(1): 99-102




(PDF emailed within 0-6 h: $19.90)

Accession: 010941699

Download citation: RISBibTeXText

PMID: 12568309

DOI: 10.1007/bf02982612



Related references

Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin. Journal of HematoTherapy & Stem Cell Research 9(3): 367-374, 2000

Antithymocyte globulin in the management of steroid-resistant acute graft-versus-host disease. Clinical & Investigative Medicine 19(4 SUPPL ): S32, 1996

Antithymocyte globulin therapy for steroid-resistant acute graft versus host disease. American Journal of Hematology 83(10): 824-825, 2008

Dose-intensified antithymocyte globulin in steroid-resistant graft-versus-host disease after allogeneic marrow or blood stem cell transplantation. Blood 90(10 SUPPL 1 PART 1): 104A, Nov 15, 1997

Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease. Biology of Blood and Marrow Transplantation 8(1): 40-46, 2002

Treatment of acute graft-versus-host disease with low-dose, alternate-day antithymocyte globulin. Haematologica 87(9): 973-978, September, 2002

Use of antithymocyte globulin for treatment of steroid-refractory acute graft-versus-host disease: An international practice survey. Bone Marrow Transplantation 28(10): 945-950, 2001

Combination antithymocyte globulin and soluble TNF alpha inhibitor (etanercept) +/- mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease. Bone Marrow Transplantation 37(12): 1143-1147, 2006

Effectiveness of low-dose antithymocyte globulin in patients with acute graft-versus-host disease. Blood 96(11 Part 2): 340b, November 16, 2000

Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment. Biology of Blood and Marrow Transplantation 8(3): 155-160, 2002

Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin. Bone Marrow Transplantation 27(10): 1059-1064, May 2, 2001

Acute graft-versus-host disease in thalassaemic marrow transplantation with low-dose antithymocyte globulin. Eastern Mediterranean Health Journal 5(3): 465-469, 2000

Successful treatment of cyclosporine-resistant chronic graft-versus-host disease with antithymocyte globulin and FK506. Blood 86(10 SUPPL 1): 948A, 1995

Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone. Transplantation 40(2): 162-166, 1985

Antithymocyte globulin in the treatment of acute graft-versus-host-disease A retrospective analysis of five patients. Blood 94(10 SUPPL 1 PART 2): 366b, Nov 15, 1999